Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
May 10, 2016 $2.25 $2.31 $2.13 $2.31 186 836
May 09, 2016 $2.33 $2.40 $2.20 $2.23 241 509
May 06, 2016 $2.50 $2.57 $2.33 $2.34 231 220
May 05, 2016 $2.25 $2.70 $2.20 $2.55 477 988
May 04, 2016 $2.64 $2.73 $2.58 $2.72 168 806
May 03, 2016 $2.67 $2.76 $2.60 $2.68 94 167
May 02, 2016 $2.89 $2.89 $2.71 $2.72 128 607
Apr 29, 2016 $2.85 $2.91 $2.72 $2.87 114 156
Apr 28, 2016 $2.87 $2.95 $2.85 $2.85 106 249
Apr 27, 2016 $2.96 $2.96 $2.86 $2.86 60 756
Apr 26, 2016 $2.95 $3.00 $2.81 $2.94 122 496
Apr 25, 2016 $3.09 $3.14 $2.88 $2.92 142 465
Apr 22, 2016 $2.95 $3.10 $2.95 $3.09 112 786
Apr 21, 2016 $2.81 $3.15 $2.80 $2.92 229 579
Apr 20, 2016 $2.75 $2.84 $2.61 $2.84 210 645
Apr 19, 2016 $2.90 $2.95 $2.75 $2.78 292 011
Apr 18, 2016 $3.16 $3.19 $2.91 $2.92 399 034
Apr 15, 2016 $3.05 $3.18 $3.00 $3.05 154 685
Apr 14, 2016 $3.03 $3.16 $2.92 $3.03 286 174
Apr 13, 2016 $2.96 $3.05 $2.86 $2.98 401 472
Apr 12, 2016 $2.90 $3.02 $2.74 $2.97 231 103
Apr 11, 2016 $3.18 $3.28 $2.82 $2.87 515 834
Apr 08, 2016 $3.40 $3.44 $3.00 $3.17 528 509
Apr 07, 2016 $3.10 $3.45 $2.96 $3.40 463 254
Apr 06, 2016 $2.88 $3.25 $2.85 $3.15 850 003
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT